Literature DB >> 1563206

Influence of time of administration on verapamil pharmacokinetics.

K K Hla1, A N Latham, J A Henry.   

Abstract

The plasma concentration-time profile of verapamil was studied in eight healthy drug-free volunteers after oral administration of a single 80 mg dose of the drug on six separate occasions at different times of day (4 AM, 8 AM, noon, 4 PM, 8 PM, and midnight). The median maximum plasma concentration of verapamil was significantly higher after the 8 AM and noon administrations (p less than 0.05) than at any other time. The median area under the concentration-time curve was also significantly higher (p less than 0.05) after administration at 8 AM and noon than at other times. The median time to maximum concentration was not significantly different at any time point (p greater than 0.05). It is possible that concentration-related adverse effects of verapamil could be avoided by choosing the time of day when the drug is prescribed. This concept may also apply to other drugs that have circadian effects in their pharmacokinetic profiles.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1563206     DOI: 10.1038/clpt.1992.35

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN: 0009-9236            Impact factor:   6.875


  2 in total

1.  Influence of ABCB1 gene polymorphisms on the pharmacokinetics of verapamil among healthy Chinese Han ethnic subjects.

Authors:  Li-Mei Zhao; Xiao-Jing He; Feng Qiu; Ya-Xin Sun; Jesse Li-Ling
Journal:  Br J Clin Pharmacol       Date:  2009-09       Impact factor: 4.335

2.  Chronopharmacology of intravenous and oral modified release verapamil.

Authors:  K Dilger; K Eckhardt; U Hofmann; K Kucher; G Mikus; M Eichelbaum
Journal:  Br J Clin Pharmacol       Date:  1999-04       Impact factor: 4.335

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.